Patients on Remdesivir and/or other clinical trials.Patients with acute exacerbation of severe comorbidities like heart disorders Chronic Obstructive Pulmonary Disease (COPD), Heart Failure New York Heart Association (NYHA) Class 3 and 4 and/or diseases with severe oxygenation problems.Patient unable to perform oro-nasopharyngeal decolonization.
0 Comments
Leave a Reply. |